leniolisib(CDZ 173)
10mM in DMSO
- Product Code: 158033
CAS:
1354690-24-6
| Molecular Weight: | 450.46 g./mol | Molecular Formula: | C₂₁H₂₅F₃N₆O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used to treat activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency disorder. It works by selectively inhibiting the PI3K delta enzyme, which plays a key role in the overactivation of immune cells seen in APDS. By modulating this pathway, it helps reduce lymphoproliferation, improves immune function, and decreases the frequency of infections in affected patients. It is taken orally and is designed for long-term management of the condition, particularly in adults and children over 12 years old.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿8,800.00 |
+
-
|
leniolisib(CDZ 173)
Used to treat activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency disorder. It works by selectively inhibiting the PI3K delta enzyme, which plays a key role in the overactivation of immune cells seen in APDS. By modulating this pathway, it helps reduce lymphoproliferation, improves immune function, and decreases the frequency of infections in affected patients. It is taken orally and is designed for long-term management of the condition, particularly in adults and children over 12 years old.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :